デフォルト表紙
市場調査レポート
商品コード
1689993

プロテオミクス市場規模、シェア、成長分析:装置技術別、試薬別、サービス別、ソフトウェア別、用途別、エンドユーザー別、地域別 - 産業予測 2025~2032年

Proteomics Market Size, Share, and Growth Analysis, By Instrumentation Technology, By Reagent, By Service, By Software, By Application, By End User, By Region - Industry Forecast 2025-2032


出版日
発行
SkyQuest
ページ情報
英文 157 Pages
納期
3~5営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
プロテオミクス市場規模、シェア、成長分析:装置技術別、試薬別、サービス別、ソフトウェア別、用途別、エンドユーザー別、地域別 - 産業予測 2025~2032年
出版日: 2025年03月21日
発行: SkyQuest
ページ情報: 英文 157 Pages
納期: 3~5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

プロテオミクス市場規模は2023年に318億米ドルと評価され、2024年の361億6,000万米ドルから2032年には1,009億9,000万米ドルに成長し、予測期間(2025-2032年)のCAGRは13.7%で成長する見通しです。

2022年には新たに2,000万人のがん患者が発生すると推定されるなど、慢性疾患の罹患率が上昇していることが、プロテオミクス市場の成長を大きく後押ししています。効率的な診断方法への需要が高まるにつれ、医薬品開発や研究開発におけるプロテオミクスの用途が拡大し、市場はさらに拡大しています。プロテオミクスは、生物学的システムにおけるタンパク質の複雑な役割と関係に焦点を当てた研究分野であり、疾患の特定や新規治療法の探索において重要な役割を果たしています。タンパク質の構造、機能、RNAやDNAなど他の分子との相互作用を緻密に解析することで、プロテオミクスは複雑な生物学的プロセスの理解に貢献し、ヘルスケアソリューションの発展に寄与しています。このように、プロテオミクス市場は、緊急の医療課題に対応することで、力強い拡大を遂げています。

目次

イントロダクション

  • 調査の目的
  • 調査範囲
  • 定義

調査手法

  • 情報調達
  • 二次と一次データの方法
  • 市場規模予測
  • 市場の前提条件と制限

エグゼクティブサマリー

  • 世界市場の見通し
  • 供給と需要の動向分析
  • セグメント別機会分析

市場力学と見通し

  • 市場概要
  • 市場規模
  • 市場力学
    • 促進要因と機会
    • 抑制要因と課題
  • ポーターの分析

主な市場の考察

  • 重要成功要因
  • 競合の程度
  • 主な投資機会
  • 市場エコシステム
  • 市場の魅力指数(2024年)
  • PESTEL分析
  • マクロ経済指標
  • バリューチェーン分析
  • 価格分析
  • 特許分析
  • 規制分析
  • ケーススタディ
  • 顧客と購買基準の分析
  • 貿易分析

プロテオミクス市場規模:装置技術別 & CAGR(2025-2032)

  • 市場概要
  • 分光法
    • 質量分析
    • NMR分光法
    • CD分光法
  • クロマトグラフィー
    • 高速液体クロマトグラフィー
    • イオンクロマトグラフィー
    • アフィニティークロマトグラフィー
    • 超臨界流体クロマトグラフィー
  • 電気泳動
    • ゲル電気泳動
    • キャピラリー電気泳動
  • タンパク質マイクロアレイ
    • バイオチップ
    • ラボオンチップ
    • プロテインチップ
    • マイクロアレイ機器
    • 統合システム
    • マイクロアレイスキャナ
    • アレイヤー
  • X線結晶構造解析
  • 表面プラズモン共鳴
  • タンパク質分画
  • その他の計測技術

プロテオミクス市場規模:試薬別& CAGR(2025-2032)

  • 市場概要
  • 免疫測定試薬
  • 分光試薬
  • クロマトグラフィー試薬
  • タンパク質マイクロアレイ試薬
  • X線結晶構造解析試薬
  • 電気泳動試薬
  • タンパク質分画試薬
  • その他の試薬

プロテオミクス市場規模:サービス別& CAGR(2025-2032)

  • 市場概要
  • コアプロテオミクスサービス
    • タンパク質同定サービス
    • 定量的プロテオミクスサービス
    • タンパク質特性評価サービス
    • タンパク質精製サービス
    • タンパク質分離サービス
    • タンパク質配列解析サービス
    • カスタムアッセイサービス
  • バイオインフォマティクスサービス

プロテオミクス市場規模:ソフトウェア別 & CAGR(2025-2032)

  • 市場概要
  • バイオインフォマティクスツール
  • バイオインフォマティクスデータベース

プロテオミクス市場規模:用途別& CAGR(2025-2032)

  • 市場概要
  • 臨床診断
    • がん
    • 感染症
    • 糖尿病
    • 神経疾患
    • 自己免疫疾患
    • 心血管疾患
    • その他の臨床診断アプリケーション
  • 医薬品の発見と開発
    • ターゲットの発見
    • リード識別
    • リード最適化
    • 前臨床研究
  • その他の用途

プロテオミクス市場規模:エンドユーザー別& CAGR(2025-2032)

  • 市場概要
  • バイオ医薬品企業
  • 学術研究機関
  • 病院
  • 臨床検査室
  • その他のエンドユーザー

プロテオミクス市場規模:地域別& CAGR(2025-2032)

  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • スペイン
    • フランス
    • 英国
    • イタリア
    • その他欧州地域
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカ
    • ブラジル
    • その他ラテンアメリカ地域
  • 中東・アフリカ
    • GCC諸国
    • 南アフリカ
    • その他中東・アフリカ

競合情報

  • 上位5社の比較
  • 主要企業の市場ポジショニング(2024年)
  • 主な市場企業が採用した戦略
  • 最近の市場動向
  • 企業の市場シェア分析(2024年)
  • 主要企業の企業プロファイル
    • 企業の詳細
    • 製品ポートフォリオ分析
    • 企業のセグメント別シェア分析
    • 収益の前年比比較(2022-2024)

主要企業プロファイル

  • Thermo Fisher Scientific(USA)
  • Agilent Technologies(USA)
  • Waters Corporation(USA)
  • Bruker Corporation(Germany)
  • Danaher Corporation(USA)
  • GE Healthcare Life Sciences(UK)
  • Bio-Rad Laboratories(USA)
  • Shinwa Chemical Industries(Japan)
  • Nexelis(Canada)
  • Proteome Sciences(UK)
  • Kyowa Kirin(Japan)

結論と提言

目次
Product Code: SQMIG35G2281

Proteomics Market size was valued at USD 31.8 billion in 2023 and is poised to grow from USD 36.16 billion in 2024 to USD 100.99 billion by 2032, growing at a CAGR of 13.7% during the forecast period (2025-2032).

The rising incidence of chronic illnesses, including an estimated 20 million new cancer cases in 2022, is significantly propelling the growth of the proteomics market. As the demand for efficient diagnostic methods escalates, the expanding applications of proteomics in drug development and research further enhance this market. Proteomics-a field study focusing on the intricate roles and relationships of proteins within biological systems-plays a crucial role in disease identification and the exploration of novel treatment options. By meticulously analyzing protein structures, functions, and interactions with other molecules such as RNA and DNA, proteomics contributes to understanding complex biological processes and fosters advancements in healthcare solutions. As such, the proteomics market is experiencing robust expansion as it addresses urgent medical challenges.

Top-down and bottom-up approaches were used to estimate and validate the size of the Proteomics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Proteomics Market Segments Analysis

Global Proteomics Market is segmented by Instrumentation Technology, Reagent, Service, Software, Application, End User and region. Based on Instrumentation Technology, the market is segmented into Spectroscopy,Chromatography, Electrophoresis, Protein Microarrays, X-Ray Crystallography, Surface Plasmon Resonance, Protein Fractionation and Other Instrumentation Technologies. Based on Reagent, the market is segmented into Immunoassay Reagents, Spectroscopy Reagents, Chromatography Reagents, Protein Microarray Reagents, X-Ray Crystallography Reagents, Electrophoresis Reagents, Protein Fractionation Reagents and Other Reagents. Based on Service, the market is segmented into Core Proteomics Services and Bioinformatics Services. Based on Software, the market is segmented into Bioinformatics Tools and Bioinformatics Databases. Based on Application, the market is segmented into Clinical Diagnostics, Drug Discovery & Development and Other Applications. Based on End User, the market is segmented into Biopharmaceutical Companies, Academic And Research Institutes, Hospitals, Clinical Laboratories and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Proteomics Market

The proteomics market is primarily driven by significant advancements in technology that have dramatically enhanced sensitivity and resolution. These innovations have not only allowed for high-throughput and multiplexed analyses but also improved data integration and sample preparation methods. Such developments have transformed the understanding of the proteome, leading to a more comprehensive exploration of proteins and their functions. As a result, these breakthroughs have played a pivotal role in stimulating the growth of the proteomics market, paving the way for new applications and research opportunities that capitalize on advanced analytical capabilities.

Restraints in the Proteomics Market

One significant restraint in the proteomics market is the challenge of navigating disparate regulatory frameworks across different countries. The lack of universally accepted standards can complicate the adoption of proteomic technologies, as varying regulations may restrict their implementation. This inconsistency can hinder international collaborations and partnerships, ultimately resulting in prolonged product approval processes. Consequently, the absence of a cohesive regulatory environment creates barriers to market growth, as companies may face delays in launching their innovations and may struggle to meet differing compliance requirements across regions, thus stifling the overall potential of the proteomics industry.

Market Trends of the Proteomics Market

The global proteomics market is experiencing significant growth driven by rapid technological advancements in mass spectrometry and next-generation sequencing. These innovations enhance the sensitivity and accuracy of protein analysis, rendering complex biological processes more comprehensible to researchers. As a result, proteomics has become integral to biomarker discovery, facilitating the identification of specific proteins associated with various diseases. This trend reflects a broader demand for precision medicine, where tailored treatments can be developed based on detailed protein profiles. Consequently, the proteomics market is poised for sustained expansion, appealing to pharmaceutical and diagnostic sectors seeking innovative solutions in disease management.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2024
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Patent Analysis
  • Regulatory Analysis
  • Case Studies
  • Customer And Buying Criteria Analysis
  • Trade Analysis

Global Proteomics Market Size by Instrumentation Technology & CAGR (2025-2032)

  • Market Overview
  • Spectroscopy
    • Mass Spectrometry
    • NMR Spectroscopy
    • CD Spectroscopy
  • Chromatography
    • High-Performance Liquid Chromatography
    • Ion Chromatography
    • Affinity Chromatography
    • Supercritical Fluid Chromatography
  • Electrophoresis
    • Gel Electrophoresis
    • Capillary Electrophoresis
  • Protein Microarrays
    • Biochips
    • Lab-On-Chips
    • Protein Chips
    • Microarray Instruments
    • Integrated Systems
    • Microarray Scanners
    • Arrayers
  • X-Ray Crystallography
  • Surface Plasmon Resonance
  • Protein Fractionation
  • Other Instrumentation Technologies

Global Proteomics Market Size by Reagent & CAGR (2025-2032)

  • Market Overview
  • Immunoassay Reagents
  • Spectroscopy Reagents
  • Chromatography Reagents
  • Protein Microarray Reagents
  • X-Ray Crystallography Reagents
  • Electrophoresis Reagents
  • Protein Fractionation Reagents
  • Other Reagents

Global Proteomics Market Size by Service & CAGR (2025-2032)

  • Market Overview
  • Core Proteomics Services
    • Protein Identification Services
    • Quantitative Proteomics Services
    • Protein Characterization Services
    • Protein Purification Services
    • Protein Separation Services
    • Protein Sequencing Services
    • Custom Assay Services
  • Bioinformatics Services

Global Proteomics Market Size by Software & CAGR (2025-2032)

  • Market Overview
  • Bioinformatics Tools
  • Bioinformatics Databases

Global Proteomics Market Size by Application & CAGR (2025-2032)

  • Market Overview
  • Clinical Diagnostics
    • Cancer
    • Infectious Diseases
    • Diabetes
    • Neurological Disorders
    • Autoimmune Diseases
    • Cardiovascular Diseases
    • Other Clinical Diagnostic Applications
  • Drug Discovery & Development
    • Target Discovery
    • Lead Identification
    • Lead Optimization
    • Preclinical Studies
  • Other Applications

Global Proteomics Market Size by End User & CAGR (2025-2032)

  • Market Overview
  • Biopharmaceutical Companies
  • Academic And Research Institutes
  • Hospitals
  • Clinical Laboratories
  • Other End Users

Global Proteomics Market Size & CAGR (2025-2032)

  • North America (Instrumentation Technology, Reagent, Service, Software, Application, End User)
    • US
    • Canada
  • Europe (Instrumentation Technology, Reagent, Service, Software, Application, End User)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Instrumentation Technology, Reagent, Service, Software, Application, End User)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Instrumentation Technology, Reagent, Service, Software, Application, End User)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Instrumentation Technology, Reagent, Service, Software, Application, End User)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2024
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2024
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

  • Thermo Fisher Scientific (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Agilent Technologies (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Waters Corporation (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bruker Corporation (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Danaher Corporation (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • GE Healthcare Life Sciences (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bio-Rad Laboratories (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Shinwa Chemical Industries (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Nexelis (Canada)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Proteome Sciences (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Kyowa Kirin (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations